1. Home
  2. CRSP vs KC Comparison

CRSP vs KC Comparison

Compare CRSP & KC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$49.80

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Kingsoft Cloud Holdings Limited

KC

Kingsoft Cloud Holdings Limited

HOLD

Current Price

$10.73

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
KC
Founded
2013
2012
Country
Switzerland
China
Employees
N/A
15225
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.3B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CRSP
KC
Price
$49.80
$10.73
Analyst Decision
Buy
Strong Buy
Analyst Count
17
3
Target Price
$70.29
$18.00
AVG Volume (30 Days)
1.7M
1.5M
Earning Date
05-11-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$289,590,000.00
N/A
Revenue This Year
$807.72
$30.93
Revenue Next Year
$172.52
$20.45
P/E Ratio
N/A
N/A
Revenue Growth
9169.85
N/A
52 Week Low
$40.76
$10.29
52 Week High
$78.48
$18.52

Technical Indicators

Market Signals
Indicator
CRSP
KC
Relative Strength Index (RSI) 45.11 31.77
Support Level $46.15 N/A
Resistance Level $59.61 $11.78
Average True Range (ATR) 2.91 0.50
MACD -0.35 -0.20
Stochastic Oscillator 9.92 8.80

Price Performance

Historical Comparison
CRSP
KC

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About KC Kingsoft Cloud Holdings Limited

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.

Share on Social Networks: